Dyakov I.N. - Список публикаций

Список записей

Отображать:

ФАРМАКОЭКОНОМИЧЕСКОЕ СРАВНЕНИЕ ФИКСИРОВАННОЙ КОМБИНАЦИИ ИНСУЛИНА ГЛАРГИН И ЛИКСИСЕНАТИДА С "СЕМЕЙСТВОМ" ИНСУЛИНА ДЕГЛУДЕК ПРИ САХАРНОМ ДИАБЕТЕ 2 ТИПА

Article

Дьяков И.Н., Зырянов С.К.

Качественная клиническая практика. 2020. С. 4-14

THE PHARMACOECONOMIC EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

Article

Зырянов С.К., Дьяков И.Н., Жуперин А.А., Егорова Д.А., Мосолова Е.С.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 120. 2020. С. 82-91

FN3 PROTEIN FRAGMENT CONTAINING TWO TYPE III FIBRONECTIN DOMAINS FROM B. LONGUM GT15 BINDS TO HUMAN TUMOR NECROSIS FACTOR ALPHA IN VITRO

Article

Dyakov I.N., Mavletova D.A., Chernyshova I.N., Snegireva N.A., Gavrilova M.V., Bushkova K.K., Dyachkova M.S., Alekseeva M.G., Danilenko V.N.

Anaerobe. Том 65. 2020.

PHARMACOECONOMIC EFFICACY OF ATESOLIZUMAB COMPARED WITH OTHER PD-1 INHIBITORS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AFTER CHEMOTHERAPY

Article

Zyryanov S.K., Diyakov I.N.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 13. 2020. С. 5-12

PHARMACOECONOMIC COMPARISON OF INSULIN GLARGINE AND INSULIN DETEMIR IN DIABETES MELLITUS TYPE 2

Article

Дьяков И.Н., Зырянов С.К.

Качественная клиническая практика. 2020. С. 4-14

ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Article

Зырянов С.К., Белевский А.С., Дьяков И.Н.

Астма и аллергия. 2019. С. 28-37

CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Article

Zyrianov S.K., Diakov I.N.

Medical Technologies. Assessment and Choice. Том 36. 2019. С. 59-68

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH CARIPRAZINE IN SCHIZOPHRENIA

Article

Dyakov I.N., Zyryanov S.K.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 119. 2019. С. 66-77

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2019. С. 4-14

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2019. С. 23-32

PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS

Article

Zyryanov S.K., Dyakov I.N., Khachatryan N.N.

Качественная клиническая практика. 2019. С. 55-69

BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS

Article

Diakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.

Medical Technologies. Assessment and Choice. 2019. С. 71-80

MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA

Article

Zyryanov Sergey, Dyakov Ilya, Karpov Oleg

Качественная клиническая практика. 2019. С. 4-12

PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION

Article

Zyryanov S.K., Diyakov I.N., Avdeev S.N.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 268-278

HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2

Article

Ziryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2018. С. 4-13

Страница 2 из 3. Записи с 16 по 30 из 39

Другие авторы

Rodionova Irina

Записей: 1

Mischenko A.V.

Записей: 3